CompletedEarly Phase 1

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

United States30 participantsStarted 2013-07

Plain-language summary

The purpose of this study is determine if using Impact Advanced Recovery® before and after RC surgery helps reduce surgical complications.

Who can participate

Age range40 Years – 90 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men undergoing RC surgery for primary bladder cancer Exclusion Criteria: * Patients with swallowing difficulties or unable to tolerate oral intake * Evidence of metastatic disease * Weight loss ≥ 10% (with respect to usual body weight) in the 6 months prior to surgery or BMI ≤ 18.5 * Patients undergoing cystectomy for non-bladder primary malignancy or cancer type other than urothelial * Active viral infections such as Human immunodeficiency virus (HIV) positive, hepatitis, or who have a known immunodeficient state * Prior history of gouty arthritis or uric acid stones * Patients with milk, soy, or fish allergies

What they're measuring

Immune and Inflammation Response

Timeframe: Change from Baseline to Day 30

Trial details

NCT IDNCT01868087

SponsorJill Hamilton-Reeves, PhD RD LD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-03

View on ClinicalTrials.gov More Bladder Cancer trials